Pharmacoepidemiology of triptans in a headache centre

Cephalalgia : an International Journal of Headache
A FerrariEmilio Sternieri

Abstract

The aims of this survey were: (i) to examine the pharmacoepidemiology of triptans in a headache centre; (ii) to compare the characteristics of patients who continued to take triptans with those of patients who had discontinued them. We enrolled all migraine patients according to ICHD-II criteria, ensuring they were over 18 years of age, consecutively examined during a follow-up visit at the Headache Centre of the University Hospital of Modena from October 2008 to March 2009. Only patients who had used or were using a triptan were included. A specific questionnaire about the use and tolerability of triptans was created for the study and administered to every patient. On the whole, 343 patients (migraine without aura: 72%; chronic migraine: 26%; migraine with aura: 2%; mean age 40.4 +/- 10 years) had used or were using triptans. Most patients (72%) continued to use triptans, above all for their efficacy. The minority (28%) discontinuing them were younger and suffered from less severe migraine; 59% of them had discontinued triptans because of adverse effects. Indeed, 92% of these patients versus 57% of patients who were currently using triptans reported adverse effects (p < .0001, Fisher's exact test). The number of patients repor...Continue Reading

References

Oct 19, 1999·Cephalalgia : an International Journal of Headache·A Maassen VanDenBrinkP R Saxena
Apr 12, 2001·Cephalalgia : an International Journal of Headache·S J WangB C Shia
Feb 12, 2002·The American Journal of Medicine·Dara G Jamieson
May 15, 2002·Headache·David W DodickCarl G H Dahlöf
Feb 1, 2003·Headache·H RahimtoolaA C G Egberts
Jun 14, 2003·Arquivos de neuro-psiquiatria·Marcelo E BigalJosé G Speciali
Mar 20, 2004·Cephalalgia : an International Journal of Headache·D W Dodick
Apr 21, 2004·Cephalalgia : an International Journal of Headache·A FerrariE Sternieri
Apr 12, 2005·Journal of Cardiovascular Pharmacology·Angelica WackenforsMalin Malmsjö
May 24, 2005·Current Pain and Headache Reports·Carl G H Dahlöf
Jan 24, 2006·Cephalalgia : an International Journal of Headache·C G H Dahlöf
Apr 29, 2006·Headache·Shahram N MalikStephen D Silberstein
May 12, 2006·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A M RapoportM E Bigal
Jul 26, 2006·Neurology·Marcelo E BigalRichard B Lipton
Sep 1, 2006·Headache·Gal IferganePesach Shvartzman
Mar 16, 2007·Headache·Anna FerrariEmilio Sternieri
Aug 8, 2007·Cephalalgia : an International Journal of Headache·E PavoneA Panconesi
Mar 5, 2008·The Journal of Headache and Pain·Alessandro PanconesiRoberto Banfi
Feb 18, 2009·Headache·Roger K CadyJudith K Evans
Mar 14, 2009·Cephalalgia : an International Journal of Headache·H J MaasO E Della Pasqua

❮ Previous
Next ❯

Citations

Jan 25, 2012·Patient Preference and Adherence·Johanna C Moore, James R Miner
Feb 19, 2014·Nature Reviews. Neurology·Marina de TommasoJean Schoenen
Aug 15, 2014·The Journal of Headache and Pain·Ting-Bin ChenShuu-Jiun Wang
Sep 30, 2010·The Journal of Headache and Pain·Anna FerrariEmilio Sternieri
May 18, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·V V OsipovaN N Yahno
May 3, 2011·Current Opinion in Neurology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.